RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

265 hedge funds and large institutions have $10.7B invested in Royalty Pharma in 2021 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 106 increasing their positions, 66 reducing their positions, and 27 closing their positions.

Holders
265
Holders Change
+34
Holders Change %
+14.72%
% of All Funds
4.09%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
63
Increased
106
Reduced
66
Closed
27
Calls
$49.1M
Puts
$11.2M
Net Calls
+$37.9M
Net Calls Change
+$9.57M

Top Buyers

1
Viking Global Investors
1
Viking Global Investors
Connecticut
$411M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$880M
3
MAMU
3
Marathon Asset Management (UK)
United Kingdom
$89.4M
4
BlackRock
4
BlackRock
New York
$666M
5
State Street
5
State Street
Massachusetts
$282M

Top Sellers

1
Berkshire Hathaway
1
Berkshire Hathaway
Nebraska
$345M
2
HMC
2
Harvard Management Company
Massachusetts
$138M
3
VCG
3
Vantage Consulting Group
Virginia
$183M
4
Amundi
4
Amundi
France
$8.03M
5
Morgan Stanley
5
Morgan Stanley
New York
$2.24B
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$2.24B 56,230,690 -1,074,621 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.18B 29,636,565 -391,497 -1%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$990M 24,842,715 +144,900 +0.6%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$880M 22,079,795 +2,970,038 +16%
BlackRock
5
BlackRock
New York
$666M 16,715,324 +1,254,479 +8%
Viking Global Investors
6
Viking Global Investors
Connecticut
$411M 10,315,378 +6,174,870 +149%
Berkshire Hathaway
7
Berkshire Hathaway
Nebraska
$345M 8,648,268 -4,497,634 -34%
State Street
8
State Street
Massachusetts
$282M 7,077,330 +1,242,585 +21%
SGA
9
Siguler Guff Advisers
New York
$269M 6,761,970 – –
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$216M 5,422,203 +105,721 +2%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$211M 5,304,122 +1,136,073 +27%
Capital International Investors
12
Capital International Investors
California
$199M 4,988,792 +1,325 +0%
VCG
13
Vantage Consulting Group
Virginia
$183M 4,601,152 -3,261,390 -41%
HMC
14
Harvard Management Company
Massachusetts
$138M 3,464,990 -3,677,866 -51%
Wellington Management Group
15
Wellington Management Group
Massachusetts
$124M 3,105,308 -23,097 -0.7%
Norges Bank
16
Norges Bank
Norway
$118M 2,960,240 +99,510 +3%
MSKCC
17
Memorial Sloan Kettering Cancer Center
New York
$107M 2,680,644 – –
Janus Henderson Group
18
Janus Henderson Group
United Kingdom
$102M 2,570,179 +207,885 +9%
Aberdeen Group
19
Aberdeen Group
United Kingdom
$91.1M 2,285,899 +484,754 +27%
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$90.8M 2,277,559 +80,823 +4%
Northern Trust
21
Northern Trust
Illinois
$90.1M 2,261,622 +592,948 +36%
MAMU
22
Marathon Asset Management (UK)
United Kingdom
$89.4M 2,242,330 +2,242,330 New
SCM
23
Suvretta Capital Management
New York
$78.4M 1,967,273 +439,373 +29%
Bank of America
24
Bank of America
North Carolina
$74.6M 1,871,289 -18,362 -1%
Legal & General Group
25
Legal & General Group
United Kingdom
$73.4M 1,842,516 +347,486 +23%
1
2 3 4 5